Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v5-EN
Language French English
Date Updated 2020-08-17 2020-08-17
Drug Identification Number 02301296 02301296
Brand name CIPROFLOXACIN INJECTION CIPROFLOXACIN INJECTION
Common or Proper name CIPROFLOXACIN INJECTION CIPROFLOXACIN INJECTION
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients CIPROFLOXACIN CIPROFLOXACIN
Strength(s) 2MG 2MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 100mL & 200mL 100mL & 200mL
ATC code J01MA J01MA
ATC description QUINOLONE ANTIBACTERIALS QUINOLONE ANTIBACTERIALS
Reason for discontinuation Raw material availability Raw material availability
Anticipated discontinuation date 2020-07-31 2020-07-31
Actual discontinuation date 2020-07-31 2020-07-31
Remaining supply date 2020-07-31 2020-07-31
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments